BDSX
Biodesix, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.18
−1.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 30.21x
- Price / sales
- 2.68x
- Price / cash flow
- -13.93x
Enterprise value
- Enterprise value
- $318.0M
- EV / sales
- 3.09x
- EV / EBITDA
- -22.27x
- EV / EBIT
- -15.44x
- Market cap
- $276.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026